The Dubai Financial Services Authority of the Dubai International Financial Centre had started its foray into regulating the crypto sector by introducing investment tokens in September 2021. The spotlight is now on the DFSA as it looks to make sweeping changes to its regulatory regime concerning recognized crypto tokens as of 1 November 2022.
Companies are turning to artificial intelligence to assist in recruiting and hiring the best talent in this tight labor market. However, there’s substantial corporate oversight in assessing AI threats, while agencies like the Equal Employment Opportunity Commission in the US are closely examining AI for potential bias and other harms. In this Quick Chat video Paul Evans and Brad Newman welcome Stephen Malone of Fox Corporation to discuss blind spots in using AI in recruitment and hiring, and share to practical tips to help employers alleviate these issues. Join us to continue the discussion in-person at Baker McKenzie’s event, A Conversation with Special Guest Speaker EEOC Commissioner Keith Sonderling, taking place 27 October in Palo Alto.
The Association of Southeast Asian Nations Economic Ministers agreed to strengthen competition policy and enforcement cooperation at the 54th ASEAN Economic Ministers’ Meeting held in Siem Reap, Cambodia from 13 to 15 September 2022.
Businesses that operate in the Southeast Asia region are encouraged to undertake a timely review of their operations to ensure that they do not fall foul of competition laws.
Baker McKenzie’s Sanctions Blog published the alert titled Ukraine imposes new set of sectoral anti-Russian sanctions on 10 August 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.
With Decree dated 29 April 2022, published in the Official Gazette on 24 May 2022, the Ministry of Health approved the organizational guidelines on the “Digital model for the implementation of home-care”. The guidelines set out a reference model for the implementation of various telemedicine services in the home-care setting, through the identification of innovative processes for taking care of patients at home and the enhancement of multi-professional and multidisciplinary collaboration between the various professionals.
In the course of 2022, the Health Protection Command of the Carabinieri Corp enforced 61 orders, issued by the competent directorates general of the Ministry of Health, providing for the shutdown of websites selling different types of prescription-only medicines in breach of the existing legislation.
On 31 May 2022, the National Coordination Centre of Ethics Committees updated the templates for the conduct of clinical trials on medicinal products and clinical investigations on medical devices that identify the minimum content of the agreement between sponsors/CROs and clinical sites to ensure the uniformity of administrative, economic and insurance aspects.
With judgment No. 705 of 21 May 2022, the Administrative Court of the Tuscany Region upheld the complaint against the decision to award a tender for a framework agreement for the supply of coronary stents to the regional health service, under which tenderers were required to offer the “most recently marketed” device. In his regard, the plaintiff complained that the successful tenderer offered a product that was on the market for years, although the same product was in line with the technical requirements set out in the tender specifications.
On 11 July 2022, the Ministry of Health published the “Annual National Plan of Transitional Controls on Biocidal Products” on its website, whose purpose it is to coordinate and integrate the organization of controls on biocidal products through the harmonization of control strategies and operating procedures.
With Judgment No. 544 of 18 July 2022, the Administrative Court of the Basilicata Region dismissed the appeal against the decision to award a tender for the supply of flu vaccines to the regional health service. In this regard, the plaintiff challenged the allocation of the type and quantity of flu vaccines to be supplied into separate lots, based on the alleged violation of the principles of competition and non-discrimination.